Aclarion Inc Ordinary Shares ACON
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.41
- Day Range
- $2.43–2.50
- 52-Week Range
- $1.95–12.03
- Bid/Ask
- $2.38 / $2.47
- Shares Outstanding
- 2.88M
- Market Cap
- $7.03M
- Volume/Avg
- 7,146 / 52,985
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 43.10
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Value
- Total Number of Employees
- 11
- Website
- https://www.aclarion.com
Valuation
|
Metric
|
ACON
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.35 |
Price/Sales | 43.10 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ACON
|
|---|---|
Quick Ratio | 15.73 |
Current Ratio | 16.20 |
Interest Coverage | — |
Quick Ratio
ACON
Profitability
|
Metric
|
ACON
|
|---|---|
Return on Assets (Normalized) | −56.76% |
Return on Equity (Normalized) | −59.83% |
Return on Invested Capital (Normalized) | −64.44% |
Return on Assets
ACON
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| LOCK|@^%$$&% | LOCK|!J< | $46B | |||
| Tempus AI Inc Class A common stock
TEM
| — | LOCK|<D! | $14B | |||
| Pro Medicus Ltd ADR
PMDIY
| — | LOCK|^<D@& | $12B | |||
| Pro Medicus Ltd
PMCUF
| — | LOCK|t<$g | $12B | |||
| BrightSpring Health Services Inc
BTSG
| — | LOCK|>lC?K | $11B | |||
| Hinge Health Inc Ordinary Shares - Class A
HNGE
| — | LOCK|jLb^H | $8B | |||
| M3 Inc
MTHRF
| — | LOCK|Qq@k^ | $8B | |||
| M3 Inc ADR
MTHRY
| — | LOCK|L<@hZ | $8B | |||
| HealthEquity Inc
HQY
| — | LOCK|Qym@ | $7B | |||
| Doximity Inc Class A
DOCS
| — | LOCK|x#< | $5B |
United States